A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration
Clinical trial NCT06591598 · COMPLETED
Trial details
- NCT number
- NCT06591598
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-02
- Primary completion
- 2025-10-14
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.